Last reviewed · How we verify
Vitamin B12 Coenzyme (COBAMAMIDE)
Vitamin B12 Coenzyme (COBAMAMIDE) works by providing the body with a necessary coenzyme for various metabolic processes.
At a glance
| Generic name | COBAMAMIDE |
|---|---|
| Drug class | Methylating Agent [EPC] |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Mechanism of action
MECHANISM OF ACTION. COBALAMIN [treatment]; FOLATE [prevention]; INTRINSIC FACTOR [facilitator] -Cobalamin is essential for the synthesis of methionine from homocysteine a reaction which also requires folate. In the absence of cobalamin ie, cobalamin deficiency, tetrahydrofolate cannot be regenerated from l-methylfolic acid, and functional folate deficiency occurs ie, methyl trap hypothesis. Gastrointestinal absorption of cobalamin depends on the presence of sufficient intrinsic factor, and lack of intrinisic factor results in cobalamin deficiency.
Approved indications
- Prevention of Vitamin B12 Deficiency
Common side effects
- Diarrhea
- Polycythemia vera
- Itching
- Transitory exanthema
- Feeling of swelling of entire body
- Allergic sensitization
- Sensitivity to porcine intrinsic factor
Key clinical trials
- Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels. (NA)
- Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis (PHASE2)
- The Role of Cobamamide Supplements in Malnourished Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vitamin B12 Coenzyme CI brief — competitive landscape report
- Vitamin B12 Coenzyme updates RSS · CI watch RSS